name nAnno nOverlap fc zscore pvalue adjp or CIl CIu
R-HSA-72766 Translation 258 74 5.36 16.9 6.9e-35 3e-32 8.09 5.99 10.8
R-HSA-192823 Viral mRNA Translation 89 45 9.45 19 6e-34 1.3e-31 19.6 12.5 30.8
R-HSA-72689 Formation of a pool of free 40S subunits 101 47 8.69 18.5 2.7e-33 3.9e-31 16.8 11 25.5
R-HSA-1799339 SRP-dependent cotranslational protein targeting to membrane 93 45 9.04 18.5 7.3e-33 7.9e-31 18 11.6 27.9
R-HSA-975956 Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) 95 45 8.85 18.3 2.4e-32 2.1e-30 17.3 11.2 26.6
R-HSA-156827 L13a-mediated translational silencing of Ceruloplasmin expression 111 48 8.08 17.8 3.9e-32 2.8e-30 14.7 9.76 22
R-HSA-72706 GTP hydrolysis and joining of the 60S ribosomal subunit 112 48 8.01 17.7 6.4e-32 3.9e-30 14.5 9.62 21.6
R-HSA-72613 Eukaryotic Translation Initiation 119 48 7.54 17.1 1.9e-30 9.2e-29 13 8.73 19.3
R-HSA-72737 Cap-dependent Translation Initiation 119 48 7.54 17.1 1.9e-30 9.2e-29 13 8.73 19.3
R-HSA-927802 Nonsense-Mediated Decay (NMD) 115 47 7.63 17 3.9e-30 1.5e-28 13.3 8.86 19.8
R-HSA-975957 Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) 115 47 7.63 17 3.9e-30 1.5e-28 13.3 8.86 19.8
R-HSA-163200 Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. 118 47 7.44 16.7 1.6e-29 5.6e-28 12.7 8.51 18.9
R-HSA-1428517 The citric acid (TCA) cycle and respiratory electron transport 165 53 6 15.4 8.8e-28 2.9e-26 9.17 6.4 13
R-HSA-5663205 Infectious disease 326 72 4.13 13.6 4.2e-26 1.3e-24 5.63 4.2 7.48
R-HSA-168273 Influenza Viral RNA Transcription and Replication 133 46 6.46 15.1 8.6e-26 2.5e-24 10.1 6.84 14.8
R-HSA-168255 Influenza Life Cycle 143 47 6.14 14.7 3.2e-25 8.6e-24 9.39 6.4 13.6
R-HSA-611105 Respiratory electron transport 95 38 7.47 15.1 3.8e-24 9.7e-23 12.6 8.05 19.6
R-HSA-168254 Influenza Infection 154 47 5.7 14 1.2e-23 2.9e-22 8.41 5.77 12.1
R-HSA-8868773 rRNA processing in the nucleus and cytosol 191 50 4.89 12.9 8.8e-22 2e-20 6.81 4.77 9.6
R-HSA-72312 rRNA processing 201 50 4.65 12.4 1e-20 2.2e-19 6.35 4.46 8.93
R-HSA-6791226 Major pathway of rRNA processing in the nucleolus and cytosol 182 47 4.82 12.4 2.9e-20 6e-19 6.65 4.61 9.46
R-HSA-8953854 Metabolism of RNA 646 92 2.66 10.4 8.1e-19 1.6e-17 3.34 2.59 4.26
R-HSA-392499 Metabolism of proteins 1907 175 1.71 8.24 8.5e-15 1.6e-13 2.17 1.79 2.62
R-HSA-72695 Formation of the ternary complex, and subsequently, the 43S complex 51 21 7.69 11.4 3.5e-14 6.2e-13 12.8 6.93 23.4
R-HSA-72649 Translation initiation complex formation 58 22 7.09 11.1 6.5e-14 1.1e-12 11.2 6.24 19.8
R-HSA-72702 Ribosomal scanning and start codon recognition 58 22 7.09 11.1 6.5e-14 1.1e-12 11.2 6.24 19.8
R-HSA-72662 Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S 59 22 6.97 10.9 9.8e-14 1.6e-12 10.9 6.08 19.1
R-HSA-6799198 Complex I biogenesis 55 20 6.79 10.2 2.3e-12 3.5e-11 10.4 5.67 18.8
R-HSA-1643685 Disease 984 100 1.9 7.06 1e-10 1.5e-09 2.23 1.76 2.81
R-HSA-350562 Regulation of ornithine decarboxylase (ODC) 51 15 5.49 7.65 3.7e-08 5.3e-07 7.55 3.81 14.2
R-HSA-1430728 Metabolism 1899 151 1.49 5.59 6.5e-08 9e-07 1.73 1.42 2.11
R-HSA-5678895 Defective CFTR causes cystic fibrosis 61 16 4.9 7.27 7.8e-08 1.1e-06 6.45 3.38 11.7
R-HSA-163210 Formation of ATP by chemiosmotic coupling 18 9 9.34 8.42 1.1e-07 1.3e-06 17.9 6.28 51.2
R-HSA-8949613 Cristae formation 18 9 9.34 8.42 1.1e-07 1.3e-06 17.9 6.28 51.2
R-HSA-5628897 TP53 Regulates Metabolic Genes 86 19 4.13 6.93 9.6e-08 1.3e-06 5.16 2.9 8.77
R-HSA-5619084 ABC transporter disorders 81 18 4.15 6.77 1.9e-07 2.3e-06 5.19 2.87 8.96
R-HSA-1268020 Mitochondrial protein import 20 9 8.41 7.88 3.3e-07 3.9e-06 14.7 5.35 39.2
R-HSA-5389840 Mitochondrial translation elongation 84 18 4 6.57 3.4e-07 3.9e-06 4.95 2.75 8.52
R-HSA-5419276 Mitochondrial translation termination 86 18 3.91 6.45 5e-07 5.5e-06 4.81 2.67 8.25
R-HSA-180585 Vif-mediated degradation of APOBEC3G 54 14 4.84 6.73 6e-07 6.3e-06 6.32 3.16 12
R-HSA-5368287 Mitochondrial translation 87 18 3.87 6.38 6e-07 6.3e-06 4.74 2.63 8.12
R-HSA-8941858 Regulation of RUNX3 expression and activity 55 14 4.76 6.64 7.6e-07 7.8e-06 6.17 3.09 11.6
R-HSA-174084 Autodegradation of Cdh1 by Cdh1:APC/C 63 15 4.45 6.53 7.8e-07 7.8e-06 5.65 2.92 10.4
R-HSA-5362768 Hh mutants that don't undergo autocatalytic processing are degraded by ERAD 56 14 4.67 6.55 9.7e-07 9.5e-06 6.02 3.02 11.3
R-HSA-162909 Host Interactions of HIV factors 128 22 3.21 5.99 1e-06 9.7e-06 3.78 2.26 6.09
R-HSA-1236978 Cross-presentation of soluble exogenous antigens (endosomes) 50 13 4.86 6.5 1.5e-06 1.4e-05 6.34 3.07 12.3
R-HSA-69017 CDK-mediated phosphorylation and removal of Cdc6 51 13 4.76 6.4 1.9e-06 1.6e-05 6.17 3 11.9
R-HSA-69229 Ubiquitin-dependent degradation of Cyclin D1 51 13 4.76 6.4 1.9e-06 1.6e-05 6.17 3 11.9
R-HSA-75815 Ubiquitin-dependent degradation of Cyclin D 51 13 4.76 6.4 1.9e-06 1.6e-05 6.17 3 11.9
R-HSA-5387390 Hh mutants abrogate ligand secretion 59 14 4.43 6.29 1.9e-06 1.6e-05 5.62 2.83 10.5
R-HSA-8939902 Regulation of RUNX2 expression and activity 59 14 4.43 6.29 1.9e-06 1.6e-05 5.62 2.83 10.5
R-HSA-174154 APC/C:Cdc20 mediated degradation of Securin 67 15 4.18 6.22 1.8e-06 1.6e-05 5.22 2.71 9.48
R-HSA-180534 Vpu mediated degradation of CD4 52 13 4.67 6.31 2.4e-06 1.8e-05 6.01 2.93 11.6
R-HSA-349425 Autodegradation of the E3 ubiquitin ligase COP1 52 13 4.67 6.31 2.4e-06 1.8e-05 6.01 2.93 11.6
R-HSA-69601 Ubiquitin Mediated Degradation of Phosphorylated Cdc25A 52 13 4.67 6.31 2.4e-06 1.8e-05 6.01 2.93 11.6
R-HSA-69610 p53-Independent DNA Damage Response 52 13 4.67 6.31 2.4e-06 1.8e-05 6.01 2.93 11.6
R-HSA-69613 p53-Independent G1/S DNA damage checkpoint 52 13 4.67 6.31 2.4e-06 1.8e-05 6.01 2.93 11.6
R-HSA-8948751 Regulation of PTEN stability and activity 69 15 4.06 6.07 2.7e-06 2e-05 5.02 2.61 9.1
R-HSA-1236975 Antigen processing-Cross presentation 88 17 3.61 5.85 3.3e-06 2.4e-05 4.34 2.38 7.51
R-HSA-8854050 FBXL7 down-regulates AURKA during mitotic entry and in early mitosis 54 13 4.5 6.13 3.7e-06 2.7e-05 5.72 2.79 11
R-HSA-8878166 Transcriptional regulation by RUNX2 80 16 3.74 5.84 4e-06 2.8e-05 4.52 2.42 7.99
R-HSA-174113 SCF-beta-TrCP mediated degradation of Emi1 55 13 4.42 6.04 4.7e-06 3.1e-05 5.58 2.73 10.7
R-HSA-4641257 Degradation of AXIN 55 13 4.42 6.04 4.7e-06 3.1e-05 5.58 2.73 10.7
R-HSA-174178 APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 72 15 3.89 5.86 4.7e-06 3.1e-05 4.76 2.48 8.58
R-HSA-174184 Cdc20:Phospho-APC/C mediated degradation of Cyclin A 72 15 3.89 5.86 4.7e-06 3.1e-05 4.76 2.48 8.58
R-HSA-5358346 Hedgehog ligand biogenesis 64 14 4.09 5.89 5.4e-06 3.5e-05 5.05 2.56 9.36
R-HSA-179419 APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint 73 15 3.84 5.79 5.7e-06 3.6e-05 4.67 2.44 8.42
R-HSA-450408 AUF1 (hnRNP D0) binds and destabilizes mRNA 56 13 4.34 5.95 5.8e-06 3.7e-05 5.45 2.67 10.4
R-HSA-4641258 Degradation of DVL 57 13 4.26 5.87 7.1e-06 4.3e-05 5.33 2.62 10.1
R-HSA-5610780 Degradation of GLI1 by the proteasome 57 13 4.26 5.87 7.1e-06 4.3e-05 5.33 2.62 10.1
R-HSA-69541 Stabilization of p53 57 13 4.26 5.87 7.1e-06 4.3e-05 5.33 2.62 10.1
R-HSA-1169091 Activation of NF-kappaB in B cells 66 14 3.96 5.74 7.9e-06 4.5e-05 4.86 2.47 8.97
R-HSA-1234176 Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha 66 14 3.96 5.74 7.9e-06 4.5e-05 4.86 2.47 8.97
R-HSA-1234174 Regulation of Hypoxia-inducible Factor (HIF) by oxygen 75 15 3.74 5.66 8e-06 4.5e-05 4.52 2.37 8.12
R-HSA-176409 APC/C:Cdc20 mediated degradation of mitotic proteins 75 15 3.74 5.66 8e-06 4.5e-05 4.52 2.37 8.12
R-HSA-2262749 Cellular response to hypoxia 75 15 3.74 5.66 8e-06 4.5e-05 4.52 2.37 8.12
R-HSA-351202 Metabolism of polyamines 84 16 3.56 5.6 7.8e-06 4.5e-05 4.26 2.29 7.48
R-HSA-176814 Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins 76 15 3.69 5.59 9.5e-06 5.3e-05 4.44 2.33 7.98
R-HSA-5676590 NIK-->noncanonical NF-kB signaling 59 13 4.12 5.71 1.1e-05 5.7e-05 5.09 2.51 9.66
R-HSA-68827 CDT1 association with the CDC6:ORC:origin complex 59 13 4.12 5.71 1.1e-05 5.7e-05 5.09 2.51 9.66
R-HSA-187577 SCF(Skp2)-mediated degradation of p27/p21 60 13 4.05 5.63 1.3e-05 6.7e-05 4.99 2.46 9.44
R-HSA-5607761 Dectin-1 mediated noncanonical NF-kB signaling 60 13 4.05 5.63 1.3e-05 6.7e-05 4.99 2.46 9.44
R-HSA-5610785 GLI3 is processed to GLI3R by the proteasome 60 13 4.05 5.63 1.3e-05 6.7e-05 4.99 2.46 9.44
R-HSA-162906 HIV Infection 184 25 2.54 5.01 1.5e-05 7.9e-05 2.87 1.78 4.44
R-HSA-4086400 PCP/CE pathway 89 16 3.36 5.31 1.7e-05 8.5e-05 3.96 2.14 6.93
R-HSA-1168372 Downstream signaling events of B Cell Receptor (BCR) 80 15 3.5 5.34 1.8e-05 9e-05 4.17 2.19 7.45
R-HSA-176408 Regulation of APC/C activators between G1/S and early anaphase 80 15 3.5 5.34 1.8e-05 9e-05 4.17 2.19 7.45
R-HSA-4608870 Asymmetric localization of PCP proteins 62 13 3.92 5.48 1.9e-05 9.2e-05 4.78 2.36 9.02
R-HSA-195253 Degradation of beta-catenin by the destruction complex 81 15 3.46 5.29 2.1e-05 1e-04 4.1 2.16 7.33
R-HSA-5668541 TNFR2 non-canonical NF-kB pathway 102 17 3.11 5.1 2.6e-05 0.00012 3.62 2 6.2
R-HSA-382556 ABC-family proteins mediated transport 104 17 3.05 5.01 3.4e-05 0.00016 3.53 1.95 6.04
R-HSA-69563 p53-Dependent G1 DNA Damage Response 66 13 3.68 5.19 3.8e-05 0.00018 4.42 2.2 8.28
R-HSA-69580 p53-Dependent G1/S DNA damage checkpoint 66 13 3.68 5.19 3.8e-05 0.00018 4.42 2.2 8.28
R-HSA-174143 APC/C-mediated degradation of cell cycle proteins 86 15 3.26 5 4.5e-05 2e-04 3.81 2.01 6.78
R-HSA-453276 Regulation of mitotic cell cycle 86 15 3.26 5 4.5e-05 2e-04 3.81 2.01 6.78
R-HSA-5658442 Regulation of RAS by GAPs 68 13 3.57 5.06 5.3e-05 0.00023 4.26 2.12 7.95
R-HSA-68867 Assembly of the pre-replicative complex 68 13 3.57 5.06 5.3e-05 0.00023 4.26 2.12 7.95
R-HSA-69615 G1/S DNA Damage Checkpoints 68 13 3.57 5.06 5.3e-05 0.00023 4.26 2.12 7.95
R-HSA-5689603 UCH proteinases 97 16 3.08 4.9 5.1e-05 0.00023 3.57 1.93 6.21
R-HSA-8852276 The role of GTSE1 in G2/M progression after G2 checkpoint 78 14 3.35 4.96 5.7e-05 0.00025 3.94 2.03 7.17
R-HSA-2871837 FCERI mediated NF-kB activation 79 14 3.31 4.9 6.6e-05 0.00028 3.88 2 7.05
R-HSA-68949 Orc1 removal from chromatin 71 13 3.42 4.87 8.5e-05 0.00035 4.04 2.02 7.51
R-HSA-69052 Switching of origins to a post-replicative state 71 13 3.42 4.87 8.5e-05 0.00035 4.04 2.02 7.51
R-HSA-69300 Removal of licensing factors from origins 73 13 3.33 4.74 0.00011 0.00047 3.9 1.95 7.24
R-HSA-3858494 Beta-catenin independent WNT signaling 137 19 2.59 4.46 0.00012 5e-04 2.91 1.68 4.8
R-HSA-5607764 CLEC7A (Dectin-1) signaling 96 15 2.92 4.49 0.00016 0.00066 3.34 1.77 5.89
R-HSA-450531 Regulation of mRNA stability by proteins that bind AU-rich elements 86 14 3.04 4.52 0.00017 0.00069 3.5 1.81 6.32
R-HSA-69304 Regulation of DNA replication 76 13 3.2 4.57 0.00017 7e-04 3.71 1.86 6.87
R-HSA-70263 Gluconeogenesis 34 8 4.4 4.72 0.00034 0.0013 5.51 2.14 12.6
R-HSA-69656 Cyclin A:Cdk2-associated events at S phase entry 81 13 3 4.29 0.00034 0.0013 3.44 1.73 6.33
R-HSA-9020702 Interleukin-1 signaling 102 15 2.75 4.22 0.00032 0.0013 3.11 1.66 5.46
R-HSA-69202 Cyclin E associated events during G1/S transition  82 13 2.96 4.24 0.00038 0.0014 3.39 1.71 6.23
R-HSA-5619115 Disorders of transmembrane transporters 149 19 2.38 4.04 0.00037 0.0014 2.64 1.53 4.34
R-HSA-6807070 PTEN Regulation 140 18 2.4 3.97 0.00047 0.0018 2.66 1.52 4.43
R-HSA-5632684 Hedgehog 'on' state 85 13 2.86 4.09 0.00054 0.002 3.25 1.64 5.96
R-HSA-68874 M/G1 Transition 85 13 2.86 4.09 0.00054 0.002 3.25 1.64 5.96
R-HSA-69002 DNA Replication Pre-Initiation 85 13 2.86 4.09 0.00054 0.002 3.25 1.64 5.96
R-HSA-8953897 Cellular responses to external stimuli 493 44 1.67 3.61 0.00054 0.002 1.8 1.27 2.49
R-HSA-8878159 Transcriptional regulation by RUNX3 108 15 2.59 3.96 6e-04 0.0022 2.9 1.55 5.09
R-HSA-983705 Signaling by the B Cell Receptor (BCR) 108 15 2.59 3.96 6e-04 0.0022 2.9 1.55 5.09
R-HSA-202424 Downstream TCR signaling 98 14 2.67 3.95 0.00068 0.0024 3 1.56 5.36
R-HSA-69239 Synthesis of DNA 99 14 2.64 3.9 0.00076 0.0027 2.96 1.54 5.29
R-HSA-5687128 MAPK6/MAPK4 signaling 89 13 2.73 3.9 0.00085 0.003 3.07 1.56 5.62
R-HSA-5621481 C-type lectin receptors (CLRs) 138 17 2.3 3.66 0.0011 0.0038 2.53 1.42 4.27
R-HSA-379716 Cytosolic tRNA aminoacylation 24 6 4.67 4.28 0.0013 0.0046 5.95 1.92 15.7
R-HSA-446203 Asparagine N-linked glycosylation 299 29 1.81 3.39 0.0014 0.0047 1.95 1.27 2.9
R-HSA-8951664 Neddylation 235 24 1.91 3.35 0.0017 0.0059 2.06 1.28 3.18
R-HSA-69306 DNA Replication 108 14 2.42 3.53 0.0018 0.006 2.68 1.4 4.76
R-HSA-3299685 Detoxification of Reactive Oxygen Species 34 7 3.85 3.95 0.0018 0.0061 4.63 1.69 11
R-HSA-168249 Innate Immune System 1035 76 1.37 3 0.0024 0.008 1.47 1.13 1.89
R-HSA-2454202 Fc epsilon receptor (FCERI) signaling 126 15 2.22 3.29 0.0029 0.0096 2.43 1.31 4.22
R-HSA-1592230 Mitochondrial biogenesis 68 10 2.75 3.44 0.0031 0.01 3.09 1.4 6.14
R-HSA-202403 TCR signaling 116 14 2.25 3.23 0.0035 0.011 2.46 1.29 4.37
R-HSA-8950505 Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation 39 7 3.35 3.5 0.0042 0.013 3.91 1.45 9.06
R-HSA-2262752 Cellular responses to stress 425 36 1.58 2.92 0.0041 0.013 1.68 1.15 2.4
R-HSA-109606 Intrinsic Pathway for Apoptosis 40 7 3.27 3.42 0.0048 0.015 3.79 1.41 8.76
R-HSA-69206 G1/S Transition 124 14 2.11 2.96 0.0064 0.02 2.28 1.2 4.03
R-HSA-446652 Interleukin-1 family signaling 138 15 2.03 2.9 0.0069 0.021 2.19 1.18 3.79
R-HSA-72172 mRNA Splicing 191 19 1.86 2.85 0.0067 0.021 1.99 1.16 3.23
R-HSA-5610787 Hedgehog 'off' state 113 13 2.15 2.92 0.0072 0.022 2.33 1.19 4.2
R-HSA-983169 Class I MHC mediated antigen processing & presentation 365 31 1.59 2.72 0.0072 0.022 1.68 1.11 2.46
R-HSA-69275 G2/M Transition 195 19 1.82 2.75 0.0083 0.025 1.94 1.13 3.16
R-HSA-445355 Smooth Muscle Contraction 34 6 3.3 3.19 0.0085 0.026 3.82 1.29 9.46
R-HSA-983168 Antigen processing: Ubiquitination & Proteasome degradation 310 27 1.63 2.67 0.0085 0.026 1.72 1.1 2.59
R-HSA-6798695 Neutrophil degranulation 477 38 1.49 2.6 0.0088 0.026 1.57 1.08 2.22
R-HSA-453274 Mitotic G2-G2/M phases 197 19 1.8 2.7 0.0092 0.027 1.92 1.12 3.12
R-HSA-453279 Mitotic G1-G1/S phases 143 15 1.96 2.75 0.0095 0.028 2.1 1.14 3.63
R-HSA-379724 tRNA Aminoacylation 35 6 3.2 3.1 0.0099 0.029 3.69 1.25 9.09
R-HSA-70326 Glucose metabolism 81 10 2.31 2.81 0.011 0.031 2.52 1.15 4.94
R-HSA-189445 Metabolism of porphyrins 17 4 4.4 3.33 0.011 0.032 5.47 1.3 17.8
R-HSA-156590 Glutathione conjugation 36 6 3.11 3.02 0.011 0.032 3.56 1.21 8.75
R-HSA-68882 Mitotic Anaphase 202 19 1.76 2.59 0.012 0.034 1.87 1.09 3.03
R-HSA-2555396 Mitotic Metaphase and Anaphase 203 19 1.75 2.56 0.012 0.035 1.86 1.08 3.01
R-HSA-3700989 Transcriptional Regulation by TP53 365 30 1.54 2.48 0.013 0.035 1.62 1.06 2.38
R-HSA-76066 RNA Polymerase III Transcription Initiation From Type 2 Promoter 27 5 3.46 3.04 0.013 0.036 4.05 1.19 11
R-HSA-9020591 Interleukin-12 signaling 48 7 2.72 2.85 0.013 0.036 3.04 1.15 6.9
R-HSA-2467813 Separation of Sister Chromatids 191 18 1.76 2.52 0.014 0.038 1.87 1.07 3.07
R-HSA-76061 RNA Polymerase III Transcription Initiation From Type 1 Promoter 28 5 3.34 2.94 0.015 0.041 3.87 1.14 10.5
R-HSA-76071 RNA Polymerase III Transcription Initiation From Type 3 Promoter 28 5 3.34 2.94 0.015 0.041 3.87 1.14 10.5
R-HSA-70171 Glycolysis 61 8 2.45 2.7 0.015 0.042 2.69 1.1 5.74
R-HSA-69242 S Phase 138 14 1.9 2.52 0.016 0.042 2.02 1.07 3.55
R-HSA-71403 Citric acid cycle (TCA cycle) 19 4 3.93 3.04 0.017 0.044 4.74 1.14 15
R-HSA-8876725 Protein methylation 19 4 3.93 3.04 0.017 0.044 4.74 1.14 15
R-HSA-1362409 Mitochondrial iron-sulfur cluster biogenesis 11 3 5.09 3.23 0.018 0.048 6.66 1.13 27.9
R-HSA-6790901 rRNA modification in the nucleus and cytosol 11 3 5.09 3.23 0.018 0.048 6.66 1.13 27.9
R-HSA-72163 mRNA Splicing - Major Pathway 183 17 1.74 2.39 0.019 0.049 1.84 1.04 3.06
